Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003533 |
---|---|
Receipt number | R000004289 |
Scientific Title | A randomized Phase II Study of Bevacizumab in Combination with Docetaxel or S-1 in Patients with Non-Squamous Non-Small-Cell Lung Cancer Previously Treated with Platinum based Chemotherapy |
Date of disclosure of the study information | 2010/04/26 |
Last modified on | 2017/05/01 09:11:11 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/04/26 01:17:08 | ||
2 | Update | 2011/12/18 14:29:35 | Last follow-up date |
|
3 | Update | 2011/12/18 14:31:21 | Post marketing survey by drug manufacture etc., specified by Japanese law. Email1 |
|
4 | Update | 2013/10/28 08:13:12 | Email |
|
5 | Update | 2014/01/27 08:29:28 | Recruitment status |
|
6 | Update | 2015/10/27 14:24:15 | Interventions/Control_2 |
|
7 | Update | 2016/11/28 10:42:36 | Name of primary person or sponsor Organization |
|
8 | Update | 2017/05/01 09:11:11 | Recruitment status Date trial data considered complete Date analysis concluded URL releasing protocol Publication of results URL related to results and publications |